Lyra Therapeutics, Inc. financial data

Symbol
LYRA on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 293% % -33%
Debt-to-equity 1616% % 1378%
Return On Equity -1033% % -478%
Return On Assets -60% % 29%
Operating Margin -5885% % 15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,774,882 shares -97%
Common Stock, Shares, Outstanding 1,644,454 shares -97%
Entity Public Float $13,803,194,000 USD -90%
Common Stock, Value, Issued $2,000 USD -97%
Weighted Average Number of Shares Outstanding, Basic 1,767,814 shares 35%
Weighted Average Number of Shares Outstanding, Diluted 1,767,814 shares 35%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $600,000 USD -59%
Research and Development Expense $20,395,000 USD -59%
General and Administrative Expense $12,613,000 USD -34%
Operating Income (Loss) $35,312,000 USD 65%
Nonoperating Income (Expense) $2,380,000 USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $32,932,000 USD 66%
Income Tax Expense (Benefit) $15,000 USD -70%
Net Income (Loss) Attributable to Parent $32,947,000 USD 66%
Earnings Per Share, Basic 35 USD/shares 63%
Earnings Per Share, Diluted 35 USD/shares 63%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $22,055,000 USD -7.3%
Assets, Current $23,019,000 USD -58%
Property, Plant and Equipment, Net $1,122,000 USD -30%
Operating Lease, Right-of-Use Asset $17,575,000 USD -15%
Other Assets, Noncurrent $0 USD -100%
Assets $43,709,000 USD -45%
Accounts Payable, Current $627,000 USD -73%
Employee-related Liabilities, Current $529,000 USD -89%
Liabilities, Current $9,480,000 USD -37%
Operating Lease, Liability, Noncurrent $26,695,000 USD -15%
Liabilities $48,037,000 USD -17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $426,758,000 USD -8.4%
Stockholders' Equity Attributable to Parent $4,328,000 USD -121%
Liabilities and Equity $43,709,000 USD -45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,842,000 USD 61%
Net Cash Provided by (Used in) Financing Activities $8,644,000 USD
Net Cash Provided by (Used in) Investing Activities $7,857,000 USD 48%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 1,644,454 shares -97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,842,000 USD -49%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24,048,000 USD -6.8%
Deferred Tax Assets, Valuation Allowance $84,810,000 USD 41%
Deferred Tax Assets, Gross $88,548,000 USD 31%
Operating Lease, Liability $31,379,000 USD -11%
Depreciation $100,000 USD
Payments to Acquire Property, Plant, and Equipment $2,149,000 USD 4676%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $32,967,000 USD 66%
Lessee, Operating Lease, Liability, to be Paid $38,376,000 USD -14%
Property, Plant and Equipment, Gross $5,570,000 USD -2.9%
Operating Lease, Liability, Current $4,684,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,131,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,494,000 USD 6.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,997,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,507,000 USD -12%
Deferred Tax Assets, Operating Loss Carryforwards $41,333,000 USD 38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,642,000 USD 3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $3,738,000 USD -49%
Share-based Payment Arrangement, Expense $3,712,000 USD -41%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%